Shares of clinical-stage biopharmaceutical company focused on respiratory diseases Verona Pharma plc (VRNA) are surging more than 85% friday morning at $8.72 after the company said it has raised approximately $200 million in private placement to fund its phase III study dubbed ENHANCE in chronic obstructive pulmonary disease (COPD).

Create Account

Dark

chart

exchange

RTTNews | Jul 17, 2020 09:57AM EDT

09:57 Friday, July 17, 2020 (RTTNews.com) - Shares of clinical-stage biopharmaceutical company focused on respiratory diseases Verona Pharma plc (VRNA) are surging more than 85% friday morning at $8.72 after the company said it has raised approximately $200 million in private placement to fund its phase III study dubbed ENHANCE in chronic obstructive pulmonary disease (COPD).

The trials are planned to start later this year.

VRNA is currently trading at $8.38. It has traded in the range of $2.01- $12.89 in the past 52 weeks.

Read the original article on RTTNews ( https://www.rttnews.com/3112051/stock-alert-verona-pharma-trading-85-higher.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2020 RTTNews.com All Rights Reserved